Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Robertson

Showing results (661-670 of 683) with videos related to

Pageof 69
Sort By:
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Journal of Virology|July 8, 2011
The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challengeMatthew R Reynolds, Jonah B Sacha, Andrea M Weiler, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
Journal of Orthopaedic Trauma|December 20, 2021
Patient-Specific Precision Injury Signatures to Optimize Orthopaedic Interventions in Multiply Injured Patients (PRECISE STUDY)Todd O McKinley, Greg E Gaski, Timothy R Billiar, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Transcriptional adaptation of drug-tolerant <i>Mycobacterium tuberculosis</i> in miceElizabeth A Wynn, Christian Dide-Agossou, Matthew Reichlen, et al.
ACS Infectious Diseases|March 20, 2025
<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Mbio|October 31, 2023
Transcriptional adaptation of <i>Mycobacterium tuberculosis</i> that survives prolonged multi-drug treatment in miceElizabeth A Wynn, Christian Dide-Agossou, Matthew Reichlen, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosisAllison A Bauman, Jansy P Sarathy, Firat Kaya, et al.
Pageof 69

Showing results (661-670 of 683) with videos related to

Sort By:
Pageof 69
ACS Infectious Diseases|January 14, 2017
Structure-Activity Relationships of Spectinamide Antituberculosis Agents: A Dissection of Ribosomal Inhibition and Native Efflux Avoidance ContributionsJiuyu Liu, David F Bruhn, Robin B Lee, et al.
Journal of Virology|July 8, 2011
The TRIM5{alpha} genotype of rhesus macaques affects acquisition of simian immunodeficiency virus SIVsmE660 infection after repeated limiting-dose intrarectal challengeMatthew R Reynolds, Jonah B Sacha, Andrea M Weiler, et al.
Antimicrobial Agents and Chemotherapy|August 9, 2021
Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832Gregory T Robertson, Michelle E Ramey, Lisa M Massoudi, et al.
Life Science Alliance|November 21, 2018
Discovery of a cofactor-independent inhibitor of <i>Mycobacterium tuberculosis</i> InhAYi Xia, Yasheen Zhou, David S Carter, et al.
Journal of Orthopaedic Trauma|December 20, 2021
Patient-Specific Precision Injury Signatures to Optimize Orthopaedic Interventions in Multiply Injured Patients (PRECISE STUDY)Todd O McKinley, Greg E Gaski, Timothy R Billiar, et al.
Biorxiv : the Preprint Server for Biology|March 22, 2023
Transcriptional adaptation of drug-tolerant <i>Mycobacterium tuberculosis</i> in miceElizabeth A Wynn, Christian Dide-Agossou, Matthew Reichlen, et al.
ACS Infectious Diseases|March 20, 2025
<i>Mycobacterium tuberculosis</i> Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 CompoundDeborah Recchia, Giovanni Stelitano, Anna Egorova, et al.
Journal of Medicinal Chemistry|August 20, 2021
1,3-Diarylpyrazolyl-acylsulfonamides as Potent Anti-tuberculosis Agents Targeting Cell Wall Biosynthesis in <i>Mycobacterium tuberculosis</i>Lutete Peguy Khonde, Rudolf Müller, Grant A Boyle, et al.
Mbio|October 31, 2023
Transcriptional adaptation of <i>Mycobacterium tuberculosis</i> that survives prolonged multi-drug treatment in miceElizabeth A Wynn, Christian Dide-Agossou, Matthew Reichlen, et al.
Biorxiv : the Preprint Server for Biology|May 27, 2024
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosisAllison A Bauman, Jansy P Sarathy, Firat Kaya, et al.
Pageof 69